Skip to content

Research on the intervention effect of Fengshengli-nutrients on sarcopenia population

Research on the intervention effect of Fengshengli-nutrients on sarcopenia population

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066529
Enrollment
Unknown
Registered
2022-12-07
Start date
2022-12-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Intervention group:Nutritional Supplement
Control group:None

Sponsors

Kangning Hospital Affiliated to Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 70-85 years, no verbal communication disorder; 2. No movement disorder; 3. No serious physical injury; 4. No acute infection; 5. No history of supplementing other health products (or nutritional supplements) in the recent 1 month; 6. No history of drug or food allergy; 7. Eating through the mouth; 8. No serious heart and lung disease; 9. Male calf circumference <34 cm, female calf circumference <33 cm; 10. Male grip strength <28 kg, female grip strength <18 kg; 11. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Acute critical illness (such as serious cardiovascular and cerebrovascular diseases and complications), cancer.

Design outcomes

Primary

MeasureTime frame
Simple Physical Condition Scale;Sarcopenia Simple Scoring Scale;Grip strength;

Countries

China

Contacts

Public ContactWu Chunhua

Kangning Hospital Affiliated to Wenzhou Medical University

yujuan72@163.com+86 13676762517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026